Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.
You can find text and video tutorials here that explain how to use our system.
Novo Nordisk Pharmatech A/S
Credit rating
Company information
About the company
Novo Nordisk Pharmatech A/S (CVR number: 13246149) is a company from KØGE. The company reported a net sales of 880.4 mDKK in 2023, demonstrating a growth of 47.2 % compared to the previous year. The operating profit percentage was at 10.3 % (EBIT: 90.3 mDKK), while net earnings were 77.2 mDKK. The profitability of the company measured by Return on Assets (ROA) was 8.8 %, which can be considered good and Return on Equity (ROE) was 10.6 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 60.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Novo Nordisk Pharmatech A/S's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsNet sales (mDKK)
EBIT (mDKK)
Profitability
Solidity
Key figures (mDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 620.99 | 667.73 | 619.08 | 598.26 | 880.40 |
Gross profit | 149.29 | 145.87 | 150.86 | 22.30 | 51.18 |
EBIT | 121.14 | 153.94 | 147.12 | 41.88 | 90.30 |
Net earnings | 97.30 | 114.92 | 113.75 | 39.31 | 77.25 |
Shareholders equity total | 691.52 | 606.43 | 520.25 | 689.62 | 766.91 |
Balance sheet total (assets) | 809.39 | 745.52 | 639.92 | 966.91 | 1 266.56 |
Net debt | 160.76 | 326.61 | |||
Profitability | |||||
EBIT-% | 19.5 % | 23.1 % | 23.8 % | 7.0 % | 10.3 % |
ROA | 15.4 % | 19.8 % | 21.2 % | 6.1 % | 8.8 % |
ROE | 14.9 % | 17.7 % | 20.2 % | 6.5 % | 10.6 % |
ROI | 15.4 % | 19.8 % | 21.2 % | 6.4 % | 9.7 % |
Economic value added (EVA) | 90.28 | 119.19 | 116.65 | 7.25 | 36.07 |
Solvency | |||||
Equity ratio | 100.0 % | 100.0 % | 100.0 % | 71.3 % | 60.6 % |
Gearing | 23.3 % | 42.6 % | |||
Relative net indebtedness % | 39.2 % | 52.1 % | |||
Liquidity | |||||
Quick ratio | 0.6 | 0.6 | |||
Current ratio | 2.2 | 1.4 | |||
Cash and cash equivalents | |||||
Capital use efficiency | |||||
Trade debtors turnover (days) | 43.8 | 26.7 | |||
Net working capital % | 45.0 % | 19.8 % | |||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | A | AA |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
... and more!
No registration needed.